Bruker Corp

NASDAQ: BRKR    
Share price (5/17/24): $75.07    
Market cap (5/17/24): $10.9 billion
10 Bruker Corp Expert Interviews, now on BamSEC.
 Powered by Tegus.

Material Contracts Filter

EX-10.31
from 10-K 49 pages Warranty Agreement by and Between Bruker Invest AG Tecfin S.À R.L. Mr. Christoph Gauer Eliman and Eliman 2 With Respect to Tecinvest S.À R.L. Tecbid S.À R.L. Elitech Mepco Sas Elitech Group Sas and Tecbid US, Inc. and All Their Direct and Indirect Subsidiaries Dated: February 27, 2024
12/34/56
EX-10.30
from 10-K 68 pages Securities Purchase Agreement by and Between Bruker Invest AG, on the One Hand, and the Sellers Identified Herein, on the Other Hand, With Respect to Tecinvest S.À R.L. Eliman S.A.S. Eliman 2 S.A.S. Dated: February 27, 2024 - II
12/34/56
EX-10.29
from 10-K 16 pages From: Bruker Invest AG, a Stock Company, Organized Under the Laws of Switzerland, Having Its Registered Office at Industriestrasse 26, Fallenden, Ch-8117, Switzerland and Registered With the Commercial Register of Canton Zurich Under the Number Che-100.756.943 (The “Promisor”); To: Tecfin S.À R.L., a Private Limited Liability Company (Société À Responsabilité Limitée) Organized Under the Laws of Grand Duchy of Luxembourg, Having Its Registered Office at 53, Boulevard Royal, L – 2449 Luxembourg and Registered With the Trade and Companies Register of Luxembourg Under Number B216066 (The “Beneficiary”) Strictly Private and Confidential December 23, 2023 Re: Put Option Dear Sirs
12/34/56
EX-10.1
from 8-K 160 pages Bruker Corporation Chf 50,000,000 2.60% Series a Senior Notes Due April 15, 2036 and Chf 50,000,000 2.62% Series B Senior Notes Due April 15, 2039 Note Purchase Agreement Dated February 8, 2024
12/34/56
EX-10.1
from 8-K 188 pages Bruker Corporation Chf 50,000,000 2.56% Series a Senior Notes Due April 15, 2034 Chf 146,000,000 2.62% Series B Senior Notes Due April 15, 2036 and Chf 135,000,000 2.71% Series C Senior Notes Due April 15, 2039 Note Purchase Agreement Dated February 1, 2024
12/34/56
EX-10.1
from 10-Q Pdf Courtesy Copy
12/34/56
EX-10.15
from 10-K 12 pages Bruker Corporation 2022 Short-Term Incentive Compensation Program
12/34/56
EX-10.1
from 8-K 134 pages Bruker Corporation Chf 300,000,000 0.88% Series a Senior Notes Due December 8, 2031 and €150,000,000 1.03% Series B Senior Notes Due December 8, 2031 Note Purchase Agreement Dated December 7, 2021
12/34/56
EX-10.2
from 10-Q 19 pages First Amendment to the Note Purchase Agreement
12/34/56
EX-10.1
from 10-Q 23 pages First Amendment to the Note Purchase Agreement
12/34/56
EX-10.27
from 10-K 3 pages Supplement to the Managing Director Employment Contract Dated 28 June 2012 Between Bruker Daltonik Gmbh Fahrenheitstr. 4 28359 Bremen - Hereinafter Referred to as ‘Company’ - And Mr. Jürgen Srega Hohenkampsweg 24f 28355 Bremen Nachtrag Zum Geschäftsführeranstellungs Vertrag Vom 28. Juni 2012 Zwischen Der Bruker Daltonik Gmbh Fahrenheitstr. 4 28359 Bremen - Im Folgenden „gesellschaft“ Genannt - Und Herrn Jürgen Srega Hohenkampsweg 24f 28355 Bremen
12/34/56
EX-10.3
from 8-K 124 pages Bruker Corporation Chf 297,000,000 1.01% Senior Notes Due December 11, 2029 Note Purchase Agreement Dated December 11, 2019
12/34/56
EX-10.1
from 10-Q 25 pages Purchase and Sale Agreement
12/34/56
EX-10.3
from 10-Q 5 pages Bruker Corporation Restricted Stock Unit Agreement Under 2016 Incentive Compensation Plan
12/34/56
EX-10.2
from 10-Q 7 pages Bruker Corporation Non-Qualified Stock Option Agreement Under 2016 Incentive Compensation Plan
12/34/56
EX-10.1
from 10-Q 7 pages Bruker Corporation Incentive Stock Option Agreement Under 2016 Incentive Compensation Plan
12/34/56
EX-10.1
from 8-K 9 pages Bruker Corporation 2019 Short-Term Incentive Compensation Program
12/34/56
EX-10.1
from 8-K 13 pages [Form Of] Indemnification Agreement
12/34/56
EX-10.2
from 10-Q 8 pages Contract of Employment Between
12/34/56
EX-10.1
from 10-Q ~5 pages Thank You for Doing a Very Good Job for Bruker as Our Interim CFO. It Is My Great Pleasure to Confirm My Offer for You to Become Bruker’s Chief Financial Officer (CFO), Reporting to Me, and Dotted-Line to the Audit Committee. Sincerely, /S/ Frank H. Laukien Frank H. Laukien President & Chief Executive Officer Accepted and Agreed: /S/ Gerald Herman Gerald Herman Date
12/34/56